<?xml version="1.0" encoding="UTF-8"?>
<ref id="B68-pharmaceuticals-13-00283">
 <label>68.</label>
 <element-citation publication-type="journal">
  <person-group person-group-type="author">
   <name>
    <surname>Assis</surname>
    <given-names>L.C.</given-names>
   </name>
   <name>
    <surname>Straliotto</surname>
    <given-names>M.R.</given-names>
   </name>
   <name>
    <surname>Engel</surname>
    <given-names>D.</given-names>
   </name>
   <name>
    <surname>Hort</surname>
    <given-names>M.A.</given-names>
   </name>
   <name>
    <surname>Dutra</surname>
    <given-names>R.C.</given-names>
   </name>
   <name>
    <surname>de Bem</surname>
    <given-names>A.F.</given-names>
   </name>
  </person-group>
  <article-title>Beta-Caryophyllene protects the C6 glioma cells against glutamate-induced excitotoxicity through the Nrf2 pathway</article-title>
  <source>Neuroscience</source>
  <year>2014</year>
  <volume>279</volume>
  <fpage>220</fpage>
  <lpage>231</lpage>
  <pub-id pub-id-type="doi">10.1016/j.neuroscience.2014.08.043</pub-id>
  <pub-id pub-id-type="pmid">25194788</pub-id>
 </element-citation>
</ref>
